4th Quarter - Amendment
BOEHRINGER INGELHEIM USA CORPORATION, FORMERLY REPORTED AS BOEHRINGER INGELHEIM PHARMACEUTICALS, INC for BOEHRINGER INGELHEIM USA CORPORATION
Firm
Income
—
Expenses
$748,150
Expense method
A: Lobbying Disclosure Act definitions
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 4th Quarter - Report | Jan 20, 2012 | $748,150 | Replaced |
| 4th Quarter - Amendment (this page) | Jan 30, 2012 | $748,150 | Yes |
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Health Issues HCR
Health Care Reform; Pricing/Rebates; Importation; Coverage; Independent Patient Advisory Board
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY CHEVALIER EFANTIS | — |
| PAUL ROMNESS | — |
| ALANNA PORTER TEMME New | — |
Pharmacy PHA
Drug Shortages; The Preserving Access to Life Savings Medicines Act (S. 296)
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY CHEVALIER EFANTIS | — |
| JONATHAN REA MCPHERSON New | — |
| PAUL ROMNESS | — |
| ALANNA PORTER TEMME New | — |
Copyright/Patent/Trademark CPT
Patent Settlements; H.R. 1706 and S. 5369
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY CHEVALIER EFANTIS | — |
| JONATHAN REA MCPHERSON New | — |
| PAUL ROMNESS | — |
| ALANNA PORTER TEMME New | — |
Budget/Appropriations BUD
Rebates for Dual Eligibles and Low Income Subsidy Populations in Medicare Pard D/Debt Ceiling
| Lobbyist | Covered position, as disclosed |
|---|---|
| AMY CHEVALIER EFANTIS | — |
| JONATHAN REA MCPHERSON New | — |
| ALANNA PORTER TEMME New | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.